SENATE 1131118th CongressRead twice and referred to the Committee on Health, Education, Labor, and Pensions.
Drug Price Transparency Act of 2023
- Last Action
- 3/30/2023
Actions
- 2023-03-30Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2023-03-30Introduced in Senate
CRS Summary
As of 2023-03-30 (00)
Drug Price Transparency Act of 2023
This bill provides statutory authority for the limitation on which type of prescription drug rebates are exempt from federal anti-kickback laws.
Specifically, a rebate from a drug manufacturer to a health insurer or pharmacy benefit manager is exempt only if the rebate (1) is disclosed to the consumer at the point of sale, or (2) is a flat fee paid for pharmacy benefit management services.
Cosponsors (1)
- Cindy Hyde-Smith (R-MS)
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.